{
  "nctId": "NCT03310983",
  "briefTitle": "Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation",
  "officialTitle": "Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation",
  "protocolDocument": {
    "nctId": "NCT03310983",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-03-19",
    "uploadDate": "2023-11-30T14:14",
    "size": 613833,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03310983/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 254,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2017-11-01",
    "completionDate": "2022-08-31",
    "primaryCompletionDate": "2022-08-31",
    "firstSubmitDate": "2017-10-10",
    "firstPostDate": "2017-10-16"
  },
  "eligibilityCriteria": {
    "criteria": "Participants for this study are invited from the parent study, ADORE. Eligibility listed reflects criteria for the ADORE study.\n\nInclusion Criteria:\n\n* Agree to consume study capsules and a typical prenatal supplement of 200 mg DHA\n* Available by telephone\n\nExclusion Criteria:\n\n* Expecting multiple infants\n* Gestational age at baseline \\<12 weeks or \\>20 weeks\n* Unable or unwilling to agree to consume capsules until delivery\n* Unwilling to discontinue use of another prenatal supplement with DHA that contains â‰¥ 200 mg DHA\n* Women with allergy to any component of DHA product (including algae), soybean oil or corn oil",
    "healthyVolunteers": true,
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Infant Fat Mass (FM)",
        "description": "Difference in FM in offspring exposed to high vs. low DHA and excessive vs. non-excessive GWG",
        "timeFrame": "24 months"
      }
    ],
    "secondary": [
      {
        "measure": "Central Fat Mass",
        "description": "Difference in FM in offspring exposed to high vs. low DHA and excessive vs. non-excessive GWG",
        "timeFrame": "24 months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 34,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:14.503Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}